Showing results (101-110 of 12,899) with videos related to

Sort By:
Pageof 1,290
Journal of the American College of Cardiology|December 24, 2019
Outcomes of Women Compared With Men After Non-ST-Segment Elevation Acute Coronary SyndromesAmy A Sarma, Eugene Braunwald, Christopher P Cannon, et al.
The Journal of Emergency Medicine|August 8, 1998
Delay in thrombolysis administration: causes of extended door-to-drug times and the asymptote effectM J Sagarin, C P Cannon, M S Cermignani, et al.
Thrombosis and Haemostasis|September 13, 2020
Edoxaban versus Warfarin in Patients with Atrial Fibrillation at the Extremes of Body Weight: An Analysis from the ENGAGE AF-TIMI 48 TrialGiuseppe Boriani, Christian T Ruff, Julia F Kuder, et al.
American Heart Journal|May 1, 1987
Differential effects of reperfusion on incidence of ventricular arrhythmias and recovery of ventricular function at 4 days following coronary occlusionJ M Arnold, E M Antman, K Przyklenk, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 1, 2001
Impact of contrast agent type (ionic versus nonionic) used for coronary angiography on angiographic, electrocardiographic, and clinical outcomes following thrombolytic administration in acute myocardial infarctionC M Gibson, A J Kirtane, S A Murphy, et al.
European Heart Journal|January 9, 2017
A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trialChristina L Fanola, Robert P Giugliano, Christian T Ruff, et al.
American Heart Journal|December 22, 2005
Combination of quantitative ST deviation and troponin elevation provides independent prognostic and therapeutic information in unstable angina and non-ST-elevation myocardial infarctionMarc S Sabatine, David A Morrow, Carolyn H McCabe, et al.
Circulation|May 9, 2002
Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarctionC Michael Gibson, Christopher P Cannon, Sabina A Murphy, et al.
Circulation|February 11, 2004
Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) substudyStephen D Wiviott, Christopher P Cannon, David A Morrow, et al.
The American Journal of Cardiology|October 7, 1998
Invasive versus conservative strategies in unstable angina and non-Q-wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 Trial. Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy. Thrombolysis In Myocardial InfarctionC P Cannon, W S Weintraub, L A Demopoulos, et al.
Pageof 1,290